World Affordable Medicines Congress 2017

The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines. Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including: Making medicines affordable CEO Panel Building scale and market share Mature and emerging market review Payers perspective and pricing trends Biosimilar development challenges Pharmacovogilance and post launch safety monitoring Clinical development strategies Developments in global intellectual property Regulatory strategy for generics and biosimilars How is the health policy landscape supporting affordable medicines? How to develop an integrated approach to biosimilar development and commercialization